Spontaneous hemodynamic improvement or stabilization and associated biopsy findings in patients with congestive

Circulation
|June 1, 1985
PubMed

Insights

Congestive cardiomyopathy (CCM) patient outcomes vary significantly. Myofibril volume fraction on endomyocardial biopsy can predict disease course and prognosis in CCM patients.

Area of Science:

  • Cardiology
  • Pathology

Background:

  • Congestive cardiomyopathy (CCM) is a complex heart condition with variable patient outcomes.
  • Predicting the clinical course and prognosis of CCM remains a challenge.

Purpose of the Study:

  • To investigate the hemodynamic courses of patients with congestive cardiomyopathy.
  • To identify factors, including endomyocardial biopsy findings, that predict disease progression or improvement.

Main Methods:

  • Hemodynamic parameters including left ventricular ejection fraction (LVEF) and pulmonary pressures were monitored in 56 CCM patients.
  • Endomyocardial biopsies were analyzed for myofibril volume fraction in 38 patients.
  • Patient outcomes (death, deterioration, stabilization, improvement) were tracked over a mean of 32.2 months.

Main Results:

  • 48% of patients experienced hemodynamic deterioration, with 5 deaths from heart failure within 24 months.
  • 52% of patients showed improvement or stabilization of their condition.
  • Reduced myofibril volume fraction (<60%) was highly predictive of deterioration and death (96% sensitivity).
  • Higher myofibril volume fraction (≥60%) predicted improvement or stabilization (93% specificity).

Conclusions:

  • Individual CCM patient courses differ significantly.
  • Myofibril volume fraction from endomyocardial biopsy provides significant prognostic information.
  • Morphological criteria, like myofibril volume fraction, can distinguish patient groups, suggesting diverse CCM pathogenesis.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...